Topological Abnormalities of Pallido-Thalamo-Cortical Circuit in Functional Brain Network of Patients With Nonchemotherapy With Non-small Cell Lung Cancer

被引:4
作者
Liu, Siwen [1 ]
Yin, Na [2 ]
Li, Chenchen [3 ]
Li, Xiaoyou [3 ]
Ni, Jie [3 ]
Pan, Xuan [3 ]
Ma, Rong [1 ]
Wu, Jianzhong [1 ]
Feng, Jifeng [1 ,3 ]
Shen, Bo [3 ]
机构
[1] Nanjing Med Univ, Jiangsu Canc Hosp, Jiangsu Inst Canc Res, Affiliated Canc Hosp,Res Ctr Clinical Oncol, Nanjing, Peoples R China
[2] Affiliated Canc Hosp Nanjing Med Univ, Jiangsu Canc Hosp, Jiangsu Inst Canc Res, Dept Radiol, Nanjing, Peoples R China
[3] Nanjing Med Univ, Jiangsu Canc Hosp, Jiangsu Inst Canc Res, Dept Oncol,Affiliated Canc Hosp, Nanjing, Peoples R China
来源
FRONTIERS IN NEUROLOGY | 2022年 / 13卷
基金
中国国家自然科学基金;
关键词
non-small cell lung cancer; resting-state; functional MRI; graph theoretical analysis; functional brain network; GRAPH-THEORETICAL ANALYSIS; COGNITIVE IMPAIRMENT; BREAST-CANCER; CHEMOTHERAPY; DISEASE; CONNECTIVITY; SYSTEM;
D O I
10.3389/fneur.2022.821470
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
IntroductionSome previous studies in patients with lung cancer have mainly focused on exploring the cognitive dysfunction and deficits of brain function associated with chemotherapy. However, little is known about functional brain alterations that might occur prior to chemotherapy. Therefore, this study aimed to evaluate brain functional changes in patients with nonchemotherapy before chemotherapy with non-small cell lung cancer (NSCLC). MethodsResting-state functional MRI data of 35 patients with NSCLC and 46 matched healthy controls (HCs) were acquired to construct functional brain networks. Graph theoretical analysis was then applied to investigate the differences of the network and nodal measures between groups. Finally, the receiver operating characteristic (ROC) curve analysis was performed to distinguish between NSCLC and HC. ResultsDecreased nodal strength was found in the left inferior frontal gyrus (opercular part), inferior frontal gyrus (triangular part), inferior occipital gyrus, and right inferior frontal gyrus (triangular part) of patients with NSCLC while increased nodal strength was found in the right pallidum and thalamus. NSCLC also showed decreased nodal betweenness in the right superior occipital gyrus. Different hub regions distribution was found between groups, however, no hub regions showed group differences in the nodal measures. Furthermore, the ROC curve analysis showed good performance in distinguishing NSCLC from HC. ConclusionThese results suggested that topological abnormalities of pallido-thalamo-cortical circuit in functional brain network might be related to NSCLC prior to chemotherapy, which provided new insights concerning the pathophysiological mechanisms of NSCLC and could serve as promising biological markers for the identification of patients with NSCLC.
引用
收藏
页数:13
相关论文
共 50 条
  • [31] Quality of life in patients with advanced non-small cell lung cancer
    Bozcuk, Hakan
    Dalmis, Berna
    Samur, Mustafa
    Ozdogan, Mustafa
    Artac, Mehmet
    Savas, Burhan
    CANCER NURSING, 2006, 29 (02) : 104 - 110
  • [32] Difference in Benefit of Chemotherapy Between Small Cell Lung Cancer Patients with Interstitial Pneumonia and Patients with Non-small Cell Lung Cancer
    Kashiwabara, Kosuke
    Semba, Hiroshi
    Fujii, Shinji
    Tsumura, Shinsuke
    Aoki, Ryota
    ANTICANCER RESEARCH, 2015, 35 (02) : 1065 - 1071
  • [33] Phase II Study of Sunitinib in Patients with Non-small Cell Lung Cancer and Irradiated Brain Metastases
    Novello, Silvia
    Camps, Carlos
    Grossi, Francesco
    Mazieres, Julien
    Abrey, Lauren
    Vernejoux, Jean-Marc
    Thall, Aron
    Patyna, Shem
    Usari, Tiziana
    Wang, Zhixiao
    Chao, Richard C.
    Scagliotti, Giorgio
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (07) : 1260 - 1266
  • [34] Non-small cell lung cancer histological subtype has prognostic impact in patients with brain metastases
    Nieder, Carsten
    Grosu, Anca L.
    Marienhagen, Kirsten
    Andratschke, Nicolaus H.
    Geinitz, Hans
    MEDICAL ONCOLOGY, 2012, 29 (04) : 2664 - 2668
  • [35] A population-based study of gefitinib in patients with non-small cell lung cancer
    Hayashibara, Kenji
    Satoh, Hiroaki
    Shinohara, Yoko
    Inagaki, Masaharu
    Kaburagi, Takayuki
    Hashimoto, Toshio
    Kurishima, Koichi
    Ishikawa, Hiroichi
    Ichimura, Hideo
    Nawa, Takeshi
    Funayama, Yasunori
    Matsumura, Takeshi
    Kagohashi, Katsunori
    Endo, Takeshi
    Furukawa, Kinya
    Kishi, Koji
    Sumi, Masaaki
    Kamiyama, Koichi
    Ishikawa, Shigemi
    MEDICAL ONCOLOGY, 2009, 26 (02) : 222 - 227
  • [36] The Effectiveness of Erlotinib Against Brain Metastases in Non-Small Cell Lung Cancer Patients
    Bai, Hao
    Han, Baohui
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2013, 36 (02): : 110 - 115
  • [37] Response to radiotherapy in brain metastases and survival of patients with non-small cell lung cancer
    Antoniou, D
    Kyprianou, K
    Stathopoulos, GP
    Skarleas, C
    Kolitsi, G
    Veslemes, M
    Dimitroulis, J
    Giamboudakis, P
    Marosis, K
    Armenaki, O
    Papageorgiou, C
    Katis, C
    ONCOLOGY REPORTS, 2005, 14 (03) : 733 - 736
  • [38] Efficacy of Surgical Treatment for Brain Metastasis in Patients with Non-Small Cell Lung Cancer
    Kim, Sang Young
    Hong, Chang Ki
    Kim, Tae Hoon
    Hong, Je Beom
    Park, Chul Hwan
    Chang, Yoon Soo
    Kim, Hyung Jung
    Ahn, Chul Min
    Byun, Min Kwang
    YONSEI MEDICAL JOURNAL, 2015, 56 (01) : 103 - 111
  • [39] Outcome of Stereotactic Radiosurgery for Patients with Non-Small Cell Lung Cancer Metastatic to The Brain
    Mariya, Yasushi
    Sekizawa, Genichirou
    Matsuoka, Yoshisuke
    Seki, Hirobumi
    Sugawara, Takayuki
    JOURNAL OF RADIATION RESEARCH, 2010, 51 (03) : 333 - 342
  • [40] Levels of serum bilirubin in small cell lung cancer and non-small cell lung cancer patients
    Jiang, Da
    Shi, Jian
    Yuan, Meng
    Duan, Xiaoyang
    Li, Lihua
    Li, Qian
    CELLULAR AND MOLECULAR BIOLOGY, 2018, 64 (06) : 71 - 76